Product Details:
| Composition | Erdafitinib |
| Strength | 4mg |
| Brand Name | Erdanat |
| Packaging Size | 28 Capsules |
| Form | Tablet |
| Manufacturer | Natco Pharma |
| Packaging Type | Bottle |
| Treatment | cGVHD |
| Country of Origin | India |
Erdafitinib (Balversa) is an oral FGFR inhibitor approved by the FDA for treating metastatic urothelial (bladder) cancer in patients with specific FGFR3/FGFR2 genetic alterations who have progressed after platinum-based chemotherapy.